CION Ameerpet
If your child has been diagnosed with a brainstem glioma, you need clarity, not jargon. Here is what DIPG is, the signs to watch, and how care is planned — gently and honestly.
A DIPG is a tumour that grows inside the pons — the part of the brainstem that runs the body's most vital functions: breathing, heartbeat, swallowing, and the nerves that move the face and eyes. The word diffuse matters: instead of forming a neat lump that a surgeon could lift out, a DIPG threads itself through healthy tissue. That is why it cannot be removed with surgery.
DIPG is a type of childhood brainstem glioma, sometimes now called a diffuse midline glioma. It is rare, and it mostly affects children between the ages of 5 and 9. If you are just starting to make sense of this diagnosis, our broader guide to childhood brain tumours and the Brain Cancer & Tumour hub give helpful context.
DIPG mainly affects children aged 5 to 9, and the U.S. National Cancer Institute reports roughly 300 children are diagnosed each year in the United States. Because the tumour grows through the brainstem rather than as a removable mass, treatment focuses on shrinking it and relieving symptoms — not surgical removal.
Most of the time, when a child is unwell it is something common and harmless — a passing bug, a growth spurt, a bit of clumsiness. What sets a brainstem glioma apart is a cluster of neurological signs that appear together and get worse over a few weeks, not slowly over many months. A tumour is the rare, don't-miss explanation.
Ask your paediatrician for an urgent brain MRI if you notice several of these appearing and steadily worsening:
A single symptom on its own — a one-off headache, a stumble — is far more likely to be something ordinary. It is the new, persistent, and progressive combination that deserves a scan. If in doubt, book a free consultation or call 18002028726.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Speak with CION's pediatric oncology team about your child's diagnosis, radiation options, supportive care, and clinical trials — we walk this journey with you.
DIPG has such a recognisable appearance on an MRI scan that experienced specialists can often diagnose it from the imaging and the child's symptoms together — sometimes without any surgery at all. The scan shows the tumour spread through the pons, which is the hallmark of the condition.
In some cases a stereotactic biopsy — a tiny, image-guided tissue sample — is recommended so the team can run molecular tests, such as the H3 K27M marker. These markers confirm the diagnosis and can open the door to clinical trials and targeted approaches. Any biopsy or neurosurgical step is coordinated with accredited neurosurgical partners; CION brings the imaging, molecular testing, and treatment plan together so your family gets one clear plan, not scattered opinions.
Because DIPG cannot be removed by surgery, treatment focuses on shrinking the tumour and easing symptoms so a child can feel and function better. Here is what care usually involves — all planned by CION's pediatric team:
Specialised radiosurgery and any neurosurgical procedure are coordinated with accredited partner facilities. CION does not offer in-house neurosurgery — instead, our team manages the whole journey and works with trusted neurosurgical partners when a procedure is needed. For the wider picture of neuro-oncology care in the city, see brain tumour treatment in Hyderabad.
This is the question every parent carries, and we answer it with honesty and gentleness. DIPG is an aggressive tumour. Published studies report that the median survival is generally under one year, with a small number of children living longer. These figures are ranges from research — they describe groups of children, not a prediction for your child. Every child is different, and your care team will talk you through what these numbers do and do not mean.
What we can promise is this: no family walks this path alone. CION's pediatric oncology team focuses on the best possible days — relieving symptoms, supporting the whole family, and helping you access clinical trials that offer hope. We make decisions for your child's healing and comfort, not for billing. Costs are explained transparently, and every child's case is reviewed by a tumour board.
Read how families have experienced CION's care — a tumour board for every patient, honest guidance, and support focused on your child's best days.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.DIPG stands for diffuse intrinsic pontine glioma. It is a tumour that grows within the pons — a part of the brainstem that controls breathing, heartbeat, swallowing, and the nerves for the face and eyes. Because it spreads through this delicate tissue rather than forming a removable lump, surgery to take it out is not possible. DIPG mainly affects children aged 5 to 9. It is rare, with roughly 300 children diagnosed each year in the United States and a smaller number in India. According to the National Cancer Institute, it is one of the most challenging childhood brain tumours. Care is coordinated under CION's pediatric cancer team.
Most childhood illnesses are common and harmless — but DIPG tends to cause a fast-moving cluster of neurological signs over weeks, not months. Classic red flags include a new squint or double vision, a drooping face on one side, trouble swallowing or a change in speech, unsteady walking, and clumsiness with the hands. Some children develop morning headaches or vomiting. If several of these appear and steadily worsen, ask your paediatrician for an urgent brain MRI. A single symptom in isolation is far more likely to be something ordinary — a passing infection or a common childhood complaint.
DIPG cannot be surgically removed. It grows diffusely — woven through healthy brainstem tissue that controls vital functions — so cutting it out would cause severe harm. There is currently no cure. However, radiation therapy can meaningfully shrink the tumour and relieve symptoms for many months, giving children a better quality of life. This is care CION delivers directly. Any biopsy, when appropriate for molecular testing, is coordinated with accredited neurosurgical partners. Because DIPG is so difficult, families are strongly encouraged to ask about clinical trials, which are described by the National Cancer Institute.
DIPG has such a distinctive appearance on an MRI scan that specialists can often diagnose it from imaging alone, together with the child's pattern of symptoms. A stereotactic biopsy — a tiny tissue sample taken under image guidance, coordinated with accredited neurosurgical partners — may be recommended to run molecular tests (such as the H3 K27M marker). These markers help confirm the diagnosis and open the door to clinical trials and targeted approaches. At CION, imaging, molecular testing, and treatment planning are brought together by the pediatric oncology team so families get one clear plan, not scattered opinions.
The mainstay of DIPG treatment is focused radiation therapy, usually given over about six weeks. Radiation does not cure the tumour, but it shrinks it and eases symptoms for a period that varies from child to child. CION delivers radiation therapy (IMRT/IGRT), steroid and symptom management, and full supportive care directly. Any neurosurgical step, and specialised radiosurgery, is coordinated with accredited partner facilities. Chemotherapy has shown limited benefit in DIPG, so families are often guided toward clinical trials testing newer, targeted approaches. Our team explains every option honestly, alongside comfort-focused care.
This is the hardest question a parent asks, and we answer it with honesty and gentleness. DIPG is an aggressive tumour, and published data show that the median survival is generally under one year, with a small number of children living longer. These are ranges from studies, not a prediction for your child — every child is different. What we can promise is that no family walks this path alone: CION's pediatric team focuses on the best possible days, symptom relief, family support, and access to trials that offer hope. We make decisions for your child's healing and comfort, not for billing.
Childhood brain tumours are complex and are best managed by a dedicated paediatric oncology team, not general adult services. At CION, all childhood brain tumours — including DIPG and other childhood brain tumours — are managed under our pediatric cancer hub, with a tumour board reviewing every child's case. We deliver radiation, medical and supportive care in-house across 35+ centres, and coordinate neurosurgery with accredited partners. To understand the wider picture of care in the city, see our brain tumour treatment in Hyderabad guide.
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified paediatric oncologist for guidance specific to your child's condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.